These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6328548)

  • 1. Electrophysiological analysis of the cholinergic effects of cimetidine and ranitidine.
    Re L; Rossini L
    Pharmacol Res Commun; 1984 Apr; 16(4):381-99. PubMed ID: 6328548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of famotidine at the mouse neuromuscular junction compared with those of cimetidine and ranitidine.
    Re L; Di Sarra B
    Pharmacology; 1989; 39(3):200-4. PubMed ID: 2587625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A further study on the kinetics of the subcellular current events at the mouse end-plate in the presence of cimetidine and ranitidine.
    Re L; Di Sarra B
    Pharmacol Res Commun; 1987 Feb; 19(2):131-45. PubMed ID: 2438708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of repetitive neuromuscular activity on the sensitivity of acetylcholine receptors.
    Ruzzier F; Scuka M
    Pflugers Arch; 1986 Feb; 406(2):99-103. PubMed ID: 3485792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aldrin-transdiol on neuromuscular facilitation and depression.
    Akkermans LM; van den Bercken J; van der Zalm J
    Eur J Pharmacol; 1975 Apr; 31(2):166-75. PubMed ID: 238851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.
    Molgó J; del Pozo E; Baños JE; Angaut-Petit D
    Br J Pharmacol; 1991 Sep; 104(1):133-8. PubMed ID: 1686201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ammodytin L on miniature and endplate potentials in neuromuscular junction of frog m. cutaneus pectoris.
    Frangez R; Krizaj I; Gubensek F; Suput D
    Pflugers Arch; 2000; 440(5 Suppl):R101-2. PubMed ID: 11005629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinacrine (mepacrine) action at frog end-plate.
    Adams PR; Feltz A
    J Physiol; 1980 Sep; 306():261-81. PubMed ID: 6257896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
    Maleque MA; Souccar C; Cohen JB; Albuquerque EX
    Mol Pharmacol; 1982 Nov; 22(3):636-47. PubMed ID: 6296656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 4-aminopyridine at the frog neuromuscular junction.
    Molgo J; Lemeignan M; Lechat P
    J Pharmacol Exp Ther; 1977 Dec; 203(3):653-63. PubMed ID: 21957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-sensitive aspects of evoked and spontaneous transmitter release at the frog neuromuscular junction.
    Barrett EF; Barrett JN; Botz D; Chang DB; Mahaffey D
    J Physiol; 1978 Jun; 279():253-73. PubMed ID: 209175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandins E1 and F2 alpha on neuromuscular transmission in the frog sartorius muscle.
    Illés P; Magazanik LG; Knoll J
    Acta Physiol Acad Sci Hung; 1977; 49(3-4):235-9. PubMed ID: 225925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotransmitter release and nerve terminal morphology at the frog neuromuscular junction affected by the dye Erythrosin B.
    Augustine GJ; Levitan H
    J Physiol; 1983 Jan; 334():47-63. PubMed ID: 6134825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms of atracurium-induced tetanic fade in the isolated rat muscle.
    Nascimento DC; Serra CS; Oliveira AC
    Basic Clin Pharmacol Toxicol; 2004 Jul; 95(1):9-14. PubMed ID: 15245570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in miniature end-plate potentials after brief nervous stimulation at the frog neuromuscular junction.
    Doherty P; Hawgood BJ; Smith IC
    J Physiol; 1984 Nov; 356():349-58. PubMed ID: 6335174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the time course of evoked quantal release at the frog neuromuscular junction using end-plate current latencies.
    Baldo GJ; Cohen IS; Van der Kloot W
    J Physiol; 1986 May; 374():503-13. PubMed ID: 3489094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic inhibition of quantal transmitter release from the magnesium-paralysed frog sartorius muscle.
    Arenson MS
    Neuroscience; 1989; 30(3):827-36. PubMed ID: 2788830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic effects of bekanamycin at the frog neuromuscular junction. Reversibility by calcium and aminopyridines.
    Uchiyama T; Molgo J; Lemeignan M
    Eur J Pharmacol; 1981 Jul; 72(4):271-80. PubMed ID: 6268416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of streptomycin on the neuromuscular junction of the frog.
    Tamaki M
    Brain Res; 1983 Apr; 265(2):241-7. PubMed ID: 6850327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.